Eli Lilly and Company’s new telehealth-based prescribing program for its obesity, diabetes and migraine drugs has built-in safeguards against violating US Food and Drug Administration rules around drug promotions and kickbacks, according to the company.
Drugs Covered By LillyDirect
-
Zepbound
Launched 4 January, the LillyDirect program offers access to independent telehealth providers to insured and uninsured individuals seeking treatment for...







